European Commission approves REZOLSTA®, a new once-daily, fixed-dose HIV therapy combining darunavir and cobicistat
- EMEA Innovative Medicine
- European Commission approves REZOLSTA® for HIV Therapy
European Commission approves REZOLSTA® for HIV Therapy
- X (Twitter)
Copy link